Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice

Pathology
Tindaro GiardinaBenhur Amanuel

Abstract

The introduction of next generation sequencing (NGS) in the routine diagnostic setting is still in the development phase and has been limited by its complexity. Targeted NGS offers an attractive alternative to performing multiple single target assays and is very useful in meeting the increasing clinical demand for testing of multiple genetic aberrations in cancer specimens. To this end, we carried out a blinded validation study on 113 tumours in a diagnostic laboratory and compared mutation results from targeted NGS with those from Sanger sequencing, pyrosequencing, competitive allele specific TaqMan polymerase chain reaction (CAST PCR) and Cobas assays. DNA was extracted from formalin fixed, paraffin embedded (FFPE) tissue samples that included core biopsies, resections and cytology samples from three common and one rare cancer types [non-small cell lung cancer (NSCLC), colorectal cancer (CRC), malignant melanoma (MM) and gastrointestinal stromal tumour (GIST)]. Libraries were prepared using the TruSight Tumour 26 gene panel and NGS was carried out on the MiSeq instrument. Results from NGS were concordant with the mutational status determined by other platforms in 107 of the 113 cases tested (94.7%). The sequencing quality for...Continue Reading

Citations

Aug 21, 2018·The Journal of Pathology·Shoko VosAnnelien L Bredenoord
Oct 31, 2018·American Journal of Clinical Dermatology·Russell J DiefenbachHelen Rizos
Jun 6, 2019·The American Journal of Surgical Pathology·Yasuni NakanumaYoshifumi Ohnishi
Dec 8, 2019·Clinical Chemistry·Ge Gao, David I Smith
Nov 15, 2019·The American Journal of Dermatopathology·Nathan T HarveyBenjamin A Wood
Nov 28, 2018·International Journal of Molecular Sciences·Chiara MolinariPaola Ulivi
Nov 27, 2019·Rheumatology·Oskar Schnappauf, Ivona Aksentijevich
Oct 28, 2020·Genome Medicine·Daniel C Koboldt
Feb 10, 2020·The Journal of Molecular Diagnostics : JMD·Swati GargTracy Stockley
Mar 6, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Anna-Lena VolckmarAlbrecht Stenzinger
Jun 10, 2021·The Journal of Cardiovascular Surgery·Jovan N Markovic, Cynthia K Shortell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.